The potential molecularly therapy target to MYCN‐amplificated neuroblastoma
Abstract Neuroblastoma (NB) is an embryonal deadly cancer in childhood driven by MYC or MYCN‐driven oncogenic signaling. The amplification of MYCN leads to malignant progression of NB and poor prognosis. Traditional chemotherapy is still a standard treatment for NB. Most of the cytostatic drugs take...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2023-08-01
|
| Col·lecció: | Clinical and Translational Discovery |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ctd2.237 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|